Wipro, a global information technology, consulting and outsourcing company has been named ‘Leader’ by technology global research and advisory firm International Data Corporation (IDC) in its report IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain ITO 2013 Vendor Assessment, Doc #HI244265, November 2013.
IDC evaluated leading Life Science Manufacturing and Supply Chain ITO Services providers across 24 criteria relating to current offering, strategy and market presence based on client inquiries, user needs assessments, and vendor and expert interviews. It identified Wipro as a leader in Worldwide Life Science Manufacturing and Supply Chain ITO.
Elaborating on Wipro’s experience with Life Sciences clients, the report states that “Wipro has extensive experience working with medical device companies, complemented by mid-level experience with pharmaceutical and biotech companies as well. The vast majority of Wipro’s life science customers are large corporations with revenues of over $1 billion, with a smaller portion spread across midsize and small firms. While more than half of its client base is North American based, it does have a significant client base across all regions of the world, including Europe, Asia, and Latin America, with multiple delivery centers in each region as well.”
IDC has rated Wipro highly for client centricity based on customer interviews conducted across all the vendors. The report further states, “Relative to other vendors discussed in this report, and based on feedback from multiple customer references, Wipro scored the highest among all vendors for account management capabilities and received high marks for technical skills and overall level of value delivered to its clients.”
Elaborating on Wipro’s vision and focus, Nitin Raizada – Global Practice Head – Industry Solutions Group, Life Sciences, Wipro, said “We continue to consolidate our position and strengthen our performance. I believe this increase in momentum is the result of a set of structured things we are doing to drive ‘sustainable’ and ‘predictable’ growth. Our continued focus on patient centricity, compliance and commercial effectiveness is showing results. We have gained traction in winning large transformation and domain specific deals by pursuing Wipro’s three-pronged strategy of programmatic mining of existing accounts, new logo pursuits and creating differentiated domain offerings to solve real problems faced by clients.”
EP News Bureau